http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104662006-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
filingDate 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eac882e27f0f0e850ad2d25aecd8421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1e9078a30d1e5c0ccf05ea611776a71
publicationDate 2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104662006-A
titleOfInvention Quinazolones Derivatives as PARP Inhibitors
abstract Compounds of formula I, wherein R 1 , R 2 , R 3 , X 1 , X 2 and Y have the meanings specified in claim 1, are inhibitors of tankyrase and can be used especially in the treatment of diseases such as cancer, Cardiovascular disease, central nervous system injury and different forms of inflammation.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106432103-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107286169-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107286169-A
priorityDate 2012-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012028578-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004014873-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0054132-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9833802-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465670129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136236985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428538204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136236976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428538431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163532911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428538657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10241003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465116237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163917148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466803220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426156816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136236972

Total number of triples: 57.